chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Feeling cold, Headache, Heart rate increased, Muscle spasms
Clinical narrative: FAST HEARTBEAT; BODY ACHES; MUSCLE CRAMP; SWOLLEN FACE; REALLY COLD; WEAKNESS; SHOOTING PAIN/MUSCLE PAIN; HEADACHE; FEVER/SHIVERS; This spontaneous report received from a patient concerned a 43 year old female. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1805022 expiry: 25/MAY/2021) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 08-APR-2021, the subject experienced fast heartbeat. On 08-APR-2021, the subject experienced body aches. On 08-APR-2021, the subject experienced muscle cramp. On 08-APR-2021, the subject experienced swollen face. On 08-APR-2021, the subject experienced really cold. On 08-APR-2021, the subject experienced weakness. On 08-APR-2021, the subject experienced shooting pain/muscle pain. On 08-APR-2021, the subject experienced headache. On 08-APR-2021, the subject experienced fever/shivers. Treatment medications (dates unspecified) included: acetylsalicylic acid/caffeine/paracetamol/salicylamide, and paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fast heartbeat, and shooting pain/muscle pain on 08-APR-2021, body aches, muscle cramp, and headache on 10-APR-2021, swollen face, and weakness on 11-APR-2021, and really cold, and fever/shivers on 09-APR-2021. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain, Pyrexia, Swelling face
Clinical narrative: FAST HEARTBEAT; BODY ACHES; MUSCLE CRAMP; SWOLLEN FACE; REALLY COLD; WEAKNESS; SHOOTING PAIN/MUSCLE PAIN; HEADACHE; FEVER/SHIVERS; This spontaneous report received from a patient concerned a 43 year old female. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1805022 expiry: 25/MAY/2021) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 08-APR-2021, the subject experienced fast heartbeat. On 08-APR-2021, the subject experienced body aches. On 08-APR-2021, the subject experienced muscle cramp. On 08-APR-2021, the subject experienced swollen face. On 08-APR-2021, the subject experienced really cold. On 08-APR-2021, the subject experienced weakness. On 08-APR-2021, the subject experienced shooting pain/muscle pain. On 08-APR-2021, the subject experienced headache. On 08-APR-2021, the subject experienced fever/shivers. Treatment medications (dates unspecified) included: acetylsalicylic acid/caffeine/paracetamol/salicylamide, and paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fast heartbeat, and shooting pain/muscle pain on 08-APR-2021, body aches, muscle cramp, and headache on 10-APR-2021, swollen face, and weakness on 11-APR-2021, and really cold, and fever/shivers on 09-APR-2021. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Asthenia, Chills, Decreased appetite, Diarrhoea, Headache
Clinical narrative: LACK OF APPETITE; WEAKNESS; CHILLS; HEADACHE; NAUSEA; FEVER; VOMITING; DIARRHEA; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose was not reported, administered on 11-APR-2021 15:20 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 11-APR-2021, the subject experienced vomiting. On 11-APR-2021, the subject experienced diarrhea. On 11-APR-2021, the subject experienced weakness. On 11-APR-2021, the subject experienced chills. On 11-APR-2021, the subject experienced headache. On 11-APR-2021, the subject experienced nausea. On 11-APR-2021, the subject experienced fever. On 12-APR-2021, the subject experienced lack of appetite. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the headache, weakness, nausea, vomiting, diarrhea, fever, chills and lack of appetite was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Vomiting
Clinical narrative: LACK OF APPETITE; WEAKNESS; CHILLS; HEADACHE; NAUSEA; FEVER; VOMITING; DIARRHEA; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose was not reported, administered on 11-APR-2021 15:20 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 11-APR-2021, the subject experienced vomiting. On 11-APR-2021, the subject experienced diarrhea. On 11-APR-2021, the subject experienced weakness. On 11-APR-2021, the subject experienced chills. On 11-APR-2021, the subject experienced headache. On 11-APR-2021, the subject experienced nausea. On 11-APR-2021, the subject experienced fever. On 12-APR-2021, the subject experienced lack of appetite. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the headache, weakness, nausea, vomiting, diarrhea, fever, chills and lack of appetite was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Dyspepsia, Headache, Menstrual disorder
Clinical narrative: MENSTRUATION 9 DAYS EARLIER THAN NORMAL; INDIGESTION; DIZZINESS; CHILLS; HEADACHE; FEVER; MUSCLE PAIN; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. No concomitant medications were reported. The batch number was not reported. Per procedure, no follow-up will be requested for this case. On an unspecified date, the subject experienced menstruation 9 days earlier than normal, indigestion, dizziness, chills, headache, fever, and muscle pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the menstruation 9 days earlier than normal, headache, indigestion, chills, fever, muscle pain and dizziness was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: MENSTRUATION 9 DAYS EARLIER THAN NORMAL; INDIGESTION; DIZZINESS; CHILLS; HEADACHE; FEVER; MUSCLE PAIN; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. No concomitant medications were reported. The batch number was not reported. Per procedure, no follow-up will be requested for this case. On an unspecified date, the subject experienced menstruation 9 days earlier than normal, indigestion, dizziness, chills, headache, fever, and muscle pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the menstruation 9 days earlier than normal, headache, indigestion, chills, fever, muscle pain and dizziness was not reported. This report was non-serious.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Decreased appetite, Disorientation, Fatigue, Gait inability
Clinical narrative: DISORIENTED; COULD NOT EVEN WALK; LOSS OF APPETITE; NO STRENGTH; WEAK LEGS; FEVER; HEADACHE; FATIGUE/EXHAUSTED/TIRED IN LEGS; This spontaneous report received from a patient concerned a 53 year old female. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043AZIA, and batch number: 043AZIA) dose was not reported, administered on 03-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 04-APR-2021, the subject experienced disoriented. On 04-APR-2021, the subject experienced could not even walk. On 04-APR-2021, the subject experienced loss of appetite. On 04-APR-2021, the subject experienced no strength. On 04-APR-2021, the subject experienced weak legs. On 04-APR-2021, the subject experienced fever. On 04-APR-2021, the subject experienced headache. On 04-APR-2021, the subject experienced fatigue/exhausted/tired in legs. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever on APR-2021, had not recovered from weak legs, no strength, headache, fatigue/exhausted/tired in legs, disoriented, and loss of appetite, and the outcome of could not even walk was not reported. This report was non-serious.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Muscular weakness, Pyrexia
Clinical narrative: DISORIENTED; COULD NOT EVEN WALK; LOSS OF APPETITE; NO STRENGTH; WEAK LEGS; FEVER; HEADACHE; FATIGUE/EXHAUSTED/TIRED IN LEGS; This spontaneous report received from a patient concerned a 53 year old female. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043AZIA, and batch number: 043AZIA) dose was not reported, administered on 03-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 04-APR-2021, the subject experienced disoriented. On 04-APR-2021, the subject experienced could not even walk. On 04-APR-2021, the subject experienced loss of appetite. On 04-APR-2021, the subject experienced no strength. On 04-APR-2021, the subject experienced weak legs. On 04-APR-2021, the subject experienced fever. On 04-APR-2021, the subject experienced headache. On 04-APR-2021, the subject experienced fatigue/exhausted/tired in legs. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever on APR-2021, had not recovered from weak legs, no strength, headache, fatigue/exhausted/tired in legs, disoriented, and loss of appetite, and the outcome of could not even walk was not reported. This report was non-serious.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Diarrhoea, Fatigue, Headache, Pain
Clinical narrative: STOMACH PAIN; DIARRHEA; VOMITING; SORE ARM; HEADACHE; FATIGUE; BODY ACHE; This spontaneous report received from a patient concerned a 75 year old female. The patient's height, and weight were not reported. The patient's past medical history included skin reaction to another vaccine in the past (MMR), and concurrent conditions included thyroid, blood pressure, and cholesterol. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802068 expiry: UNKNOWN) dose was not reported, administered on 25-MAR-2021 14:00 for prophylactic vaccination. Concomitant medications included acetylsalicylic acid for drug used for unknown indication. On 25-MAR-2021, the subject experienced body ache. On 25-MAR-2021, the subject experienced sore arm. On 25-MAR-2021, the subject experienced headache. On 25-MAR-2021, the subject experienced fatigue. On 26-MAR-2021, the subject experienced stomach pain. On 26-MAR-2021, the subject experienced diarrhea. On 26-MAR-2021, the subject experienced vomiting. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body ache, and headache, stomach pain, diarrhea, and vomiting on 27-MAR-2021, and sore arm on 08-APR-2021, and the outcome of fatigue was not reported. This report was non-serious. This case, from the same reporter is linked to 20210427911.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vomiting
Clinical narrative: STOMACH PAIN; DIARRHEA; VOMITING; SORE ARM; HEADACHE; FATIGUE; BODY ACHE; This spontaneous report received from a patient concerned a 75 year old female. The patient's height, and weight were not reported. The patient's past medical history included skin reaction to another vaccine in the past (MMR), and concurrent conditions included thyroid, blood pressure, and cholesterol. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802068 expiry: UNKNOWN) dose was not reported, administered on 25-MAR-2021 14:00 for prophylactic vaccination. Concomitant medications included acetylsalicylic acid for drug used for unknown indication. On 25-MAR-2021, the subject experienced body ache. On 25-MAR-2021, the subject experienced sore arm. On 25-MAR-2021, the subject experienced headache. On 25-MAR-2021, the subject experienced fatigue. On 26-MAR-2021, the subject experienced stomach pain. On 26-MAR-2021, the subject experienced diarrhea. On 26-MAR-2021, the subject experienced vomiting. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body ache, and headache, stomach pain, diarrhea, and vomiting on 27-MAR-2021, and sore arm on 08-APR-2021, and the outcome of fatigue was not reported. This report was non-serious. This case, from the same reporter is linked to 20210427911.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: PAIN IN JOINTS (HANDS, FEET, LEGS, KNEES, HIPS); This spontaneous report received from a patient concerned a 72 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included osteopenia in hands, abstains from alcohol, and non smoker.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose was not reported, administered on 08-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On MAR-2021, the subject experienced pain in joints (hands, feet, legs, knees, hips). Treatment medications (dates unspecified) included: Tylenol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from pain in joints (hands, feet, legs, knees, hips). This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: EXTREME BOUTS OF FATIGUE; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose, start therapy date were not reported for prophylactic vaccination.  The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced extreme bouts of fatigue, and very scary / worrisome. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the extreme bouts of fatigue and very scary / worrisome was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Hyperhidrosis, Vomiting
Clinical narrative: VOMITING; SWEATING; CHILLS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 09-APR-2021, the subject experienced vomiting.  On APR-2021, the subject experienced sweating. On APR-2021, the subject experienced chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from vomiting on 09-APR-2021, and had not recovered from sweating, and chills. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Medication error
Clinical narrative: &J COVID-19 VACCINE  ADMINISTERED 28 DAYS AFTER  MODERNA COVID-19 VACCINE  ADMINISTERED; This spontaneous report received from a pharmacist concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's concurrent conditions included kidney disease. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported,  batch number: 042121A, and 042A21A expiry: UNKNOWN) dose was not reported, administered on 04-APR-2021 for prophylactic vaccination. Concomitant medications included mrna 1273 for prophylactic vaccination. On an unspecified date, the subject experienced &j covid-19 vaccine administered 28 days after moderna covid-19 vaccine administered. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of &j covid-19 vaccine administered 28 days after moderna covid-19 vaccine administered was not reported. This report was non-serious. This case, from the same reporter is linked to 20210419970.
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: ARM FELT LIKE DEAD LEG; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On APR-2021, the subject experienced arm felt like dead leg. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of arm felt like dead leg was not reported. This report was non-serious.
Age: 58.0
Sex: U
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Nausea, Rash
Clinical narrative: DIARRHEA; FACIAL RASH; NAUSEA; HEADACHE; This spontaneous report received from a patient concerned a 58 year old of unspecified sex. The patient's height, and weight were not reported. The patient's concurrent conditions included medication allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown and expiry date: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination.  The batch number was not reported and has been requested. No concomitant medications were reported.  On 09-APR-2021, the subject experienced diarrhea. On 09-APR-2021, the subject experienced facial rash.  On 09-APR-2021, the subject experienced nausea. On 09-APR-2021, the subject experienced headache. Treatment medications (dates unspecified) included: diphenhydramine hydrochloride (Benadryl). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from diarrhea, facial rash, nausea, and headache on APR-2021. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Hyperhidrosis, Nausea
Clinical narrative: BODY ACHES; PROFUSELY SWEATING ALL NIGHT; SHAKING VERY BAD; CHILLS; BAD HEADACHE; NAUSEA; FEVER; This spontaneous report received from a parent concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 25-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, Laboratory data included: Body temperature (NR: not provided) 102 F. On 25-MAR-2021, the subject experienced body aches. On 25-MAR-2021, the subject experienced profusely sweating all night. On 25-MAR-2021, the subject experienced shaking very bad. On 25-MAR-2021, the subject experienced chills. On 25-MAR-2021, the subject experienced bad headache. On 25-MAR-2021, the subject experienced nausea. On 25-MAR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, chills, bad headache, nausea, body aches, profusely sweating all night and shaking very bad was not reported. This report was non-serious. This case, from the same reporter is linked to 20210427911.
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Tremor
Clinical narrative: BODY ACHES; PROFUSELY SWEATING ALL NIGHT; SHAKING VERY BAD; CHILLS; BAD HEADACHE; NAUSEA; FEVER; This spontaneous report received from a parent concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 25-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, Laboratory data included: Body temperature (NR: not provided) 102 F. On 25-MAR-2021, the subject experienced body aches. On 25-MAR-2021, the subject experienced profusely sweating all night. On 25-MAR-2021, the subject experienced shaking very bad. On 25-MAR-2021, the subject experienced chills. On 25-MAR-2021, the subject experienced bad headache. On 25-MAR-2021, the subject experienced nausea. On 25-MAR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, chills, bad headache, nausea, body aches, profusely sweating all night and shaking very bad was not reported. This report was non-serious. This case, from the same reporter is linked to 20210427911.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Disturbance in attention, Feeling of body temperature change, Headache, Pain
Clinical narrative: BODY ACHE; WENT FROM HOT TO COLD; BRAIN COULD NOT FOCUS; CHILLS; HEADACHE; FEVER; This spontaneous report received from a consumer concerned an 18 year old female. The patient's height, and weight were not reported. The patient's past medical history included seizure, and concurrent conditions included seasonal allergy, no alcohol, and non smoker.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 202A21A expiry: UNKNOWN) dose was not reported, administered on 11-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced body ache, feeling cold, brain could not focus, chills, headache, and fever. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the chills, body ache, headache, feeling cold, fever and brain could not focus was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: BODY ACHE; WENT FROM HOT TO COLD; BRAIN COULD NOT FOCUS; CHILLS; HEADACHE; FEVER; This spontaneous report received from a consumer concerned an 18 year old female. The patient's height, and weight were not reported. The patient's past medical history included seizure, and concurrent conditions included seasonal allergy, no alcohol, and non smoker.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 202A21A expiry: UNKNOWN) dose was not reported, administered on 11-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced body ache, feeling cold, brain could not focus, chills, headache, and fever. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the chills, body ache, headache, feeling cold, fever and brain could not focus was not reported. This report was non-serious.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Fatigue, Hypokinesia, Malaise
Clinical narrative: BLURRY VISION; WEAKNESS; FELT SICK; TIRED; COULDN'T MOVE; DIZZY; This spontaneous report received from a patient concerned a 47 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included non-alcoholic, non-smoker, no cholesterol, and varicose veins, and other pre-existing medical conditions included no known drug allergies and had a watch on eating. family history of varicose veins, thrombosis and blood clots. patient is healthy and exercise regularly. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031, and expiry: UNKNOWN) dose was not reported, administered on 15-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 16-MAR-2021, the subject experienced couldn't move. On 16-MAR-2021, the subject experienced dizzy. On 16-MAR-2021, the subject experienced felt sick. On 16-MAR-2021, the subject experienced tired. On 18-MAR-2021, the subject experienced blurry vision. On 18-MAR-2021, the subject experienced weakness. Treatment medications (dates unspecified) included: ascorbic acid/ergocalciferol/folic acid/nicotinamide/panthenol/retinol/riboflavin/thiamine hydrochloride. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from couldn't move, felt sick, and tired, had not recovered from dizzy, and the outcome of blurry vision and weakness was not reported. This report was non-serious.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Vision blurred
Clinical narrative: BLURRY VISION; WEAKNESS; FELT SICK; TIRED; COULDN'T MOVE; DIZZY; This spontaneous report received from a patient concerned a 47 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included non-alcoholic, non-smoker, no cholesterol, and varicose veins, and other pre-existing medical conditions included no known drug allergies and had a watch on eating. family history of varicose veins, thrombosis and blood clots. patient is healthy and exercise regularly. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031, and expiry: UNKNOWN) dose was not reported, administered on 15-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 16-MAR-2021, the subject experienced couldn't move. On 16-MAR-2021, the subject experienced dizzy. On 16-MAR-2021, the subject experienced felt sick. On 16-MAR-2021, the subject experienced tired. On 18-MAR-2021, the subject experienced blurry vision. On 18-MAR-2021, the subject experienced weakness. Treatment medications (dates unspecified) included: ascorbic acid/ergocalciferol/folic acid/nicotinamide/panthenol/retinol/riboflavin/thiamine hydrochloride. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from couldn't move, felt sick, and tired, had not recovered from dizzy, and the outcome of blurry vision and weakness was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Malaise
Clinical narrative: FELT SICK; This spontaneous report received from a consumer concerned multiple patients. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. Batch number was not reported and has been requested . No concomitant medications were reported. On an unspecified date, the subject experienced felt sick and stayed in bed for 24 hrs. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of felt sick and stayed in bed for 24 hrs was not reported. This report was non-serious.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: This spontaneous report received from a physician concerned a 45 year old female. The patient's height, and weight were not reported. The patient's past medical history included migraine headache, and cervical cancer. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from headache. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: INJECTION SITE PAIN; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 13-APR-2021 for prophylactic vaccination .Batch number was not reported and has been requested  No concomitant medications were reported. On 13-APR-2021, the subject experienced injection site pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of injection site pain was not reported. This report was non-serious.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Lethargy, Somnolence
Clinical narrative: FEELING BAD; LAZY; SLEEPY; This spontaneous report received from a consumer concerned a 41 year old male. The patient's height, and weight were not reported.  The patient's past medical history included rheumatic fever, and concurrent conditions included non alcoholic, and non smoker, and other pre-existing medical conditions included patient have no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 13-APR-2021, the subject experienced lazy. On 13-APR-2021, the subject experienced sleepy. On an unspecified date, the subject experienced feeling bad. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from lazy, and sleepy, and the outcome of feeling bad was not reported. This report was non-serious.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Bedridden, Chest discomfort, Fatigue
Clinical narrative: PRESSURE ON CHEST; COULD NOT GET OUT OF BED; TIREDNESS; This spontaneous report received from a patient concerned a 33 year old. The patient's height, and weight were not reported. The patient's concurrent conditions included breastfeeding, non smoker, and allergic to aspirin, and other pre-existing medical conditions included the patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 207A21A, expiry: UNKNOWN) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 13-APR-2021, the subject experienced could not get out of bed. On 13-APR-2021, the subject experienced tiredness. On 14-APR-2021, the subject experienced pressure on chest. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from tiredness, and the outcome of pressure on chest and could not get out of bed was not reported. This report was non-serious. This parent/child case is linked to 20210436123.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Hyperhidrosis, Pyrexia
Clinical narrative: SWEATING; CHILLS; HEADACHE; FEVER; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. Batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, the subject experienced sweating. On APR-2021, the subject experienced chills. On APR-2021, the subject experienced headache. On APR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sweating, chills, headache, and fever on APR-2021. This report was non-serious. This case, from the same reporter is linked to 20210428358 and 20210430032.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Malaise, Pain
Clinical narrative: BODY ACHES; CHILLS; TIREDNESS; DIFFICULTY WITH WAKING UP; RIGHT SHOULDER PAIN; NOT FEELING WELL; This spontaneous report received from a patient concerned a 46 year old female. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21A expiry: 23/JUN/2021) dose was not reported, administered on 11-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 12-APR-2021, the subject experienced difficulty with waking up. On 12-APR-2021, the subject experienced right shoulder pain. On 12-APR-2021, the subject experienced not feeling well. On 12-APR-2021, the subject experienced tiredness. On 12-APR-2021 01:00, the subject experienced chills. On 12-APR-2021 06:30, the subject experienced body aches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, chills, and tiredness on 12-APR-2021, and difficulty with waking up, and not feeling well, and had not recovered from right shoulder pain. This report was non-serious.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: BODY ACHES; CHILLS; TIREDNESS; DIFFICULTY WITH WAKING UP; RIGHT SHOULDER PAIN; NOT FEELING WELL; This spontaneous report received from a patient concerned a 46 year old female. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21A expiry: 23/JUN/2021) dose was not reported, administered on 11-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 12-APR-2021, the subject experienced difficulty with waking up. On 12-APR-2021, the subject experienced right shoulder pain. On 12-APR-2021, the subject experienced not feeling well. On 12-APR-2021, the subject experienced tiredness. On 12-APR-2021 01:00, the subject experienced chills. On 12-APR-2021 06:30, the subject experienced body aches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, chills, and tiredness on 12-APR-2021, and difficulty with waking up, and not feeling well, and had not recovered from right shoulder pain. This report was non-serious.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Chills, Diarrhoea, Dizziness, Headache
Clinical narrative: CHEST PAIN; SEVERE WATERY DIARRHEA; LIGHT HEADED; SWEATING; CHILLS; FEVER; HEADACHE; NAUSEA; DIZZY; HOT AT THE INJECTION SITE; VOMITING; This spontaneous report received from a patient concerned a 49 year old female. The patient's height, and weight were not reported.  The patient's past medical history included hysterectomy, and concurrent conditions included asthma, and other pre-existing medical conditions included patient had no known allergies.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, and expiry: 23/JUN/2021) .5 ml, administered on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 12-APR-2021, the subject experienced hot at the injection site. On 12-APR-2021, the subject experienced vomiting. On 12-APR-2021, the subject experienced dizzy. On 12-APR-2021, the subject experienced headache. On 12-APR-2021, the subject experienced nausea. On 14-APR-2021, the subject experienced chest pain. On 14-APR-2021, the subject experienced severe watery diarrhea. On 14-APR-2021, the subject experienced light headed. On 14-APR-2021, the subject experienced sweating. On 14-APR-2021, the subject experienced chills. On 14-APR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from hot at the injection site, and vomiting on 13-APR-2021, and had not recovered from headache, nausea, dizzy, severe watery diarrhea, light headed, sweating, chest pain, chills, and fever. This report was non-serious.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Injection site warmth, Nausea, Pyrexia, Vomiting
Clinical narrative: CHEST PAIN; SEVERE WATERY DIARRHEA; LIGHT HEADED; SWEATING; CHILLS; FEVER; HEADACHE; NAUSEA; DIZZY; HOT AT THE INJECTION SITE; VOMITING; This spontaneous report received from a patient concerned a 49 year old female. The patient's height, and weight were not reported.  The patient's past medical history included hysterectomy, and concurrent conditions included asthma, and other pre-existing medical conditions included patient had no known allergies.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, and expiry: 23/JUN/2021) .5 ml, administered on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 12-APR-2021, the subject experienced hot at the injection site. On 12-APR-2021, the subject experienced vomiting. On 12-APR-2021, the subject experienced dizzy. On 12-APR-2021, the subject experienced headache. On 12-APR-2021, the subject experienced nausea. On 14-APR-2021, the subject experienced chest pain. On 14-APR-2021, the subject experienced severe watery diarrhea. On 14-APR-2021, the subject experienced light headed. On 14-APR-2021, the subject experienced sweating. On 14-APR-2021, the subject experienced chills. On 14-APR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from hot at the injection site, and vomiting on 13-APR-2021, and had not recovered from headache, nausea, dizzy, severe watery diarrhea, light headed, sweating, chest pain, chills, and fever. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: SORE ARM; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on APR-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On APR-2021, the subject experienced sore arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of sore arm was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Dyspnoea, Headache, Muscle spasms
Clinical narrative: LEG CRAMPS; SHORTNESS OF BREATH; HEADACHES; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The Batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, the subject experienced leg cramps. On APR-2021, the subject experienced shortness of breath. On APR-2021, the subject experienced headaches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the leg cramps, shortness of breath and headaches was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Muscle strain, Pain, Pain in extremity
Clinical narrative: FULL BODY ACHE; PULLED CALF MUSCLE FEELING; LEG PAIN CALF; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, the subject experienced full body ache. On APR-2021, the subject experienced pulled calf muscle feeling. On APR-2021, the subject experienced leg pain calf. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from full body ache, and the outcome of leg pain calf and pulled calf muscle feeling was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: WARMTH AT INJECTION SITE; ITCHING AT INJECTION SITE; HEADACHE; SWELLING AT INJECTION SITE; RED DISCOLORATION  AT INJECTION SITE; BODY ACHES; FATIGUE; This spontaneous report received from a patient concerned a 33 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known allergies.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, and batch number: 043A21A expiry: 21-JUN-2021) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-APR-2021, the subject experienced body aches. On 09-APR-2021, the subject experienced fatigue. On 10-APR-2021, the subject experienced warmth at injection site. On 10-APR-2021, the subject experienced itching at injection site. On 10-APR-2021, the subject experienced headache. On 10-APR-2021, the subject experienced swelling at injection site. On 10-APR-2021, the subject experienced red discoloration at injection site. Treatment medications (dates unspecified) included: diphenhydramine hydrochloride. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, and fatigue on 09-APR-2021, and headache on 11-APR-2021, and had not recovered from swelling at injection site, red discoloration at injection site, itching at injection site, and warmth at injection site. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Injection site warmth, Pain
Clinical narrative: WARMTH AT INJECTION SITE; ITCHING AT INJECTION SITE; HEADACHE; SWELLING AT INJECTION SITE; RED DISCOLORATION  AT INJECTION SITE; BODY ACHES; FATIGUE; This spontaneous report received from a patient concerned a 33 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known allergies.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, and batch number: 043A21A expiry: 21-JUN-2021) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-APR-2021, the subject experienced body aches. On 09-APR-2021, the subject experienced fatigue. On 10-APR-2021, the subject experienced warmth at injection site. On 10-APR-2021, the subject experienced itching at injection site. On 10-APR-2021, the subject experienced headache. On 10-APR-2021, the subject experienced swelling at injection site. On 10-APR-2021, the subject experienced red discoloration at injection site. Treatment medications (dates unspecified) included: diphenhydramine hydrochloride. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, and fatigue on 09-APR-2021, and headache on 11-APR-2021, and had not recovered from swelling at injection site, red discoloration at injection site, itching at injection site, and warmth at injection site. This report was non-serious.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Lethargy
Clinical narrative: ARTHRALGIA; LETHARGIC; This spontaneous report received from a patient concerned a 68 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802068, expiry: UNKNOWN) dose was not reported, administered on 08-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-MAR-2021, the subject experienced arthralgia. On 09-MAR-2021, the subject experienced lethargic. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from arthralgia, and lethargic on 10-MAR-2021. This report was non-serious.
Age: 28.0
Sex: U
Vaccine: COVID19
Symptoms: Injection site erythema, Rhinorrhoea
Clinical narrative: RUNNY NOSE; REDNESS AT INJECTION SITE; This spontaneous report received from a patient concerned a 28 year old of unspecified sex. The patient's weight, height, and medical history were not reported . The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A, expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-APR-2021, the subject experienced redness at injection site. On 12-APR-2021, the subject experienced runny nose. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from redness at injection site, and runny nose. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Pyrexia, Sluggishness
Clinical narrative: SLUGGISHNESS; TIREDNESS; FEVER; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 11-APR-2021 for prophylactic vaccination. Batch number was not reported. Per procedure, no follow up will be requested for this case. No concomitant medications were reported. On 12-APR-2021, the subject experienced sluggishness. On 12-APR-2021, the subject experienced tiredness. On 12-APR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the tiredness, sluggishness and fever was not reported. This report was non-serious.